Nordstrom: Analysts' Upgrades, Downgrades - TheStreet

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

CHANGE IN RATINGS

Alfa

(ALFAA)

target boosted at Credit Suisse to $100 from $90. 2010 and 2011 EPS estimates set at 35 cents and 40 cents, respectively. Maintain Outperform rating.

Brigham Exploration

( BEXP) initiated at Credit Suisse with an Outperform rating and $17 price target. The oil & gas EP company has operations focused in North Dakota, Montana, and the Gulf Coast. Brigham could experience rapid growth. 2009 and 2010 EPS estimate set at -$0.02 and $0.16, respectively.

Ciena

(CIEN) - Get Report

downgraded at Barclays to Equal Weight from Overweight on valuation. Maintain $14 price target. 2010 and 2011 EPS estimates set at 3 cents and 46 cents, respectively.

Coach

(COH)

downgraded at Goldman from Buy to Neutral. $37 price target. Stock no longer deserves a premium valuation.

Gap

(GPS) - Get Report

upgraded at Citi to Buy from Hold as topline momentum at Old Navy and Banana Republic is encouraging. Price target raised by a dollar to $24. 2010 and 2011 EPS estimates set at $1.58 and $1.70, respectively.

Interpublic Group

(IPG) - Get Report

upgraded at Credit Suisse to Outperform from Neutral as a turnaround is expected in 2010. Price target surged to $10 from $6.50. 2009 and 2010 EPS estimates set at 13 cents and 41 cents, respectively.

Nordstrom

(JWN) - Get Report

downgraded at Goldman from Buy to Neutral. Valuation call, based on a $39 price target.

MetLife

(MET) - Get Report

upgraded at FBR from Market Perform to Outperform. $46 price target. Expect a potential ALICO acquisition would be accretive to earnings.

Motorola

( MOT) upgraded at Barclays to Overweight from Equal Weight as visibility is improving in EMS segment and for Andriod shipments. $9 price target. 2010 EPS estimate held at 21 cents, 2011 introduced at 38 cents.

Molson Coors Brewing

(TAP) - Get Report

initiated at Barclays with an Overweight rating and $50 price target. Analysts noted improving free cash flow trends, margin expansion, and cost savings. 2009 and 2010 EPS estimates set at $3.88 and $3.80, respectively.

Tenneco

(TEN) - Get Report

upgraded at Barclays. TEN upgraded to Overweight from Equal Weight as the company enters rapidly growing commercial disesel emissions control market. Price target increased to $25 from $18. 2010 EPS estimate raised to 95 cents from 67 cents.

Texas Roadhouse

(TXRD)

upgraded at Credit Suisse to Outperform from Neutral as near-term results will drive potential upside. Price target increased to $15 from $13. 2009 and 2010 EPS estimates set at 67 cents and 75 cents, respectively.

MEMC Electronic Materials

(WFR)

upgraded at Credit Suisse to Outperform from Neutral on strong cash position and valuation. Price target jumped to $19.50 from $17. 2009 and 2010 EPS estimates set at -$0.09 and $0.71, respectively.

STOCK COMMENTS / EPS CHANGES

Air Products

(APD) - Get Report

estimates cut at UBS through 2011. Company will be hurt by the strong dollar, but should still benefit from the coming industrial recovery. Buy rating and $93 price target.

Alliant Techsystems

(ATK)

numbers lowered at Goldman. Shares of ATK now seen reaching $86. Estimates also reduced, because of lower realized margins. Neutral rating.

Avon Products

(AVP) - Get Report

numbers lowered at Goldman. AVP estimates were cut through 2011. Company is seeing lower margins. Sell rating and new $30 price target.

Clorox

(CLX) - Get Report

estimates, target reduced at Goldman. Shares of CLX now seen reaching $67. Estimates also cut, to reflect currency and commodity pressures. Neutral rating.

Con-way

(CNW)

price target reduced at BofA/Merrill to $36 from $45 on an increase in costs. 2010 and 2011 EPS estimates set at $1.50 and $2.45, respectively. Maintain Buy rating.

Diamond Offshore

(DO) - Get Report

numbers cut at Goldman. Shares of DO now seen reaching $103. Estimates also reduced, because of higher cost assumptions. Neutral rating.

Starwood Hotels

(HOT)

estimates cut at Goldman through 2011. Company is facing cost pressures and seeing lower retail sales. Buy rating and $43 price target.

Illumina

(ILMA)

estimates, target lowered at Goldman. ILMN estimates were reduced through 2011. Company is seeing lower instrument sales. Neutral rating and new $39 price target.

Kellogg

(K) - Get Report

estimates, target reduced at Goldman. Shares of K now seen reaching $59. Estimates also cut, to reflect a stronger dollar. Neutral rating.

Pactiv Corp

( PTV) risk rating adjusted at Citi. PTV risk rating reduced to Medium Risk from High Risk on valuation. Citigroup maintained Buy rating and $29 price target.

Praxair

(PX)

estimates, target lowered at UBS. PX estimates were cut through 2011. Company will be hurt by the strong dollar, but has potential operating leverage. Buy rating and new $91 price target.

Ralcorp

( RAH) estimates, target raised at UBS. Shares of RAH now seen reaching $72. Estimates also boosted, as the Post cereal business is driving growth. Buy rating.

Reynolds American

(RAI)

estimates cut at Goldman through 2012. Company could lose market share and has no pension expense benefit next year. Sell rating and $53 price target.

Spirit Aerosystems

(SPR) - Get Report

numbers reduced at Goldman. SPR estimates were cut through 2011. Company is seeing lower margins, because of depreciation and pension costs. Buy rating and new $25 price target.

Sunoco

(SUN) - Get Report

estimates lowered at Goldman. SUN estimates were cut through 2013. Company seeing lower capture rates in refining and logistics earnings. Sell rating and $20 price target.

Tenneco

(TEN) - Get Report

price target higher at Credit Suisse. TEN price target lifted to $23 from $20 on strong revenue guidance. Maintain Outperform rating. 2010 and 2011 EPS estimate raised to $0.90 and $1.94, respectively.

Urban Outfitters

(URBN) - Get Report

outlook improved at Citi. URBN added to Top Picks Live as 4Q09 comps were reported inline. Maintain Buy rating and $42 price target.

Vertex Pharma

(VRTX) - Get Report

estimates lowered at Morgan Stanley. VRTX estimates were reduced through 2011. Company continues to face higher operating expenses. Overweight rating and $50 price target.

This article was written by a staff member of TheStreet.com.